Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001396814-25-000005
Filing Date
2025-01-06
Accepted
2025-01-06 18:22:49
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1736205763.html 4  
1 FORM 4 wk-form4_1736205763.xml 4 3292
  Complete submission text file 0001396814-25-000005.txt   5174
Mailing Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609
Business Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609 813-553-6680
Pacira BioSciences, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PACIRA BIOSCIENCES, INC. 5401 WEST KENNEDY BOULEVARD, SUITE 890 TAMPA FL 33609
Business Address
RIKER LAUREN (Reporting) CIK: 0001545439 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 25512794